Takeda, Eli Lilly Want Ark. Taxpayer's Actos Suit Nixed

Law360, Los Angeles (June 3, 2013, 9:59 PM EDT) -- Takeda Pharmaceuticals Co. Ltd. and Eli Lilly & Co. urged a Louisiana federal judge on Friday to dismiss a class action alleging they ripped off taxpayers by hiding the risks of their diabetes drug Actos, saying the plaintiff hadn't properly pled violations of an Arkansas constitutional prohibition on misuse of public funds.

Friday’s motion in the multidistrict litigation argues that plaintiff Greg Bowerman failed to properly plead that the pharmaceutical companies had violated the theory of illegal exaction, a cause of action under the state constitution...
To view the full article, register now.